Indeed, sEH gene deletion (EPHX2−/−) did not show any positive effect in an experimental setting of pathological remodeling and cardiac fibrosis after angiotensin II treatment [9], and, unexpectedly, increased mortality in mice due to cardiac arrest [56]. The gene discussed is AGT; the disease is cardiac arrest.